Kai Neben

7.6k total citations
111 papers, 4.2k citations indexed

About

Kai Neben is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Kai Neben has authored 111 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Hematology, 49 papers in Oncology and 37 papers in Molecular Biology. Recurrent topics in Kai Neben's work include Multiple Myeloma Research and Treatments (64 papers), Cancer Treatment and Pharmacology (16 papers) and Lymphoma Diagnosis and Treatment (15 papers). Kai Neben is often cited by papers focused on Multiple Myeloma Research and Treatments (64 papers), Cancer Treatment and Pharmacology (16 papers) and Lymphoma Diagnosis and Treatment (15 papers). Kai Neben collaborates with scholars based in Germany, France and United States. Kai Neben's co-authors include Anthony D. Ho, Hartmut Goldschmidt, Jens Hillengaß, Axel Benner, Thomas Moehler, Thomas Hielscher, Gerlinde Egerer, Dirk Hose, Peter Lichter and Stefan Delorme and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Kai Neben

107 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Neben Germany 41 2.5k 2.3k 1.5k 739 463 111 4.2k
Shmuel Yaccoby United States 38 3.7k 1.5× 3.0k 1.3× 3.0k 1.9× 522 0.7× 297 0.6× 112 5.5k
Diane C. Arthur United States 33 2.0k 0.8× 1.0k 0.5× 858 0.6× 1.1k 1.5× 895 1.9× 78 4.1k
Luen Bik To Australia 30 2.4k 1.0× 1.1k 0.5× 1.7k 1.1× 751 1.0× 207 0.4× 78 3.9k
A Hagemeijer Netherlands 45 3.2k 1.3× 2.1k 0.9× 866 0.6× 1.5k 2.0× 942 2.0× 135 5.9k
Sergej Konoplev United States 35 2.2k 0.9× 1.4k 0.6× 1.4k 0.9× 1.2k 1.7× 964 2.1× 154 4.6k
Nicole Dastugue France 40 2.4k 1.0× 1.8k 0.8× 1.1k 0.7× 1.1k 1.5× 1.4k 3.0× 121 4.9k
Bruno Paiva Spain 36 3.4k 1.4× 2.6k 1.2× 1.9k 1.3× 829 1.1× 433 0.9× 157 4.7k
Stefan Hohaus Italy 39 1.5k 0.6× 1.4k 0.6× 1.4k 0.9× 591 0.8× 1.0k 2.2× 167 4.2k
Juan Luis Garcı́a Spain 29 1.2k 0.5× 1.3k 0.6× 984 0.6× 836 1.1× 806 1.7× 127 3.2k
Scott Ely United States 28 872 0.4× 1.3k 0.6× 1.6k 1.1× 737 1.0× 1.1k 2.3× 89 3.4k

Countries citing papers authored by Kai Neben

Since Specialization
Citations

This map shows the geographic impact of Kai Neben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Neben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Neben more than expected).

Fields of papers citing papers by Kai Neben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Neben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Neben. The network helps show where Kai Neben may publish in the future.

Co-authorship network of co-authors of Kai Neben

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Neben. A scholar is included among the top collaborators of Kai Neben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Neben. Kai Neben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmitt, Michael, Patrick Wuchter, Eike C. Buss, et al.. (2014). Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma. Transfusion. 55(2). 275–283. 33 indexed citations
2.
Hundemer, Michael, Mélanie Engelhardt, Thomas Brückner, et al.. (2014). Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myeloma. Journal of Clinical Apheresis. 29(6). 299–304. 29 indexed citations
3.
Löffler, H., Kai Neben, & A. Krämer. (2014). CUP-Syndrom. Der Radiologe. 54(2). 107–111. 6 indexed citations
4.
Andrulis, Mindaugas, Nicola Lehners, David Capper, et al.. (2013). Targeting the BRAF V600E Mutation in Multiple Myeloma. Cancer Discovery. 3(8). 862–869. 171 indexed citations
5.
Schmitt, Stefan, Thomas Hielscher, Claudia D. Baldus, et al.. (2013). Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation. International Journal of Hematology. 97(6). 765–772. 2 indexed citations
6.
Geis, Steffen, Christiane Prifert, Benedikt Weißbrich, et al.. (2012). Molecular Characterization of a Respiratory Syncytial Virus Outbreak in a Hematology Unit in Heidelberg, Germany. Journal of Clinical Microbiology. 51(1). 155–162. 36 indexed citations
7.
Meißner, Tobias, Anja Seckinger, Thierry Rème, et al.. (2011). Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical Routine. Clinical Cancer Research. 17(23). 7240–7247. 30 indexed citations
8.
Hillengaß, Jens, Kerstin Fechtner, Marc‐An dré Weber, et al.. (2010). Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma. Journal of Clinical Oncology. 28(9). 1606–1610. 255 indexed citations
9.
Klein, Ulrike, Kai Neben, Thomas Hielscher, et al.. (2010). Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment. Annals of Hematology. 90(4). 429–439. 51 indexed citations
10.
Bäuerle, Tobias, Jens Hillengaß, Kerstin Fechtner, et al.. (2009). Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Importance of Whole-Body versus Spinal MR Imaging. Radiology. 252(2). 477–485. 87 indexed citations
11.
Bochtler, Tilmann, Ute Hegenbart, Christiane Heiß, et al.. (2009). Hyperdiploidy Is Rare in Patients with AL Amyloidosis – Identification of Major Cytogenetic Groups in Early Monoclonal Plasma Cell Disorders.. Blood. 114(22). 2823–2823.
12.
Schneeweiß, Andreas, et al.. (2008). Carcinoma of Unknown Primary – an Orphan Disease?. Breast Care. 3(3). 3–3. 17 indexed citations
13.
Hensel, Manfred, Axel Benner, Kai Neben, et al.. (2007). High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B‐cell chronic lymphocytic leukemia. International Journal of Cancer. 121(5). 978–983. 13 indexed citations
14.
Felsberg, Joerg, Christian Hartmann, Annegret Kunitz, et al.. (2006). Identification of novel oligodendroglioma‐associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray‐based expression profiling. International Journal of Cancer. 119(4). 792–800. 56 indexed citations
15.
Witzens‐Harig, Mathias, Thomas Moehler, Kai Neben, et al.. (2004). Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide. Annals of Hematology. 83(7). 467–470. 6 indexed citations
16.
Wrobel, Gunnar, Peter Roerig, Felix Kokocinski, et al.. (2004). Microarray‐based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. International Journal of Cancer. 114(2). 249–256. 92 indexed citations
17.
Neben, Kai, Joannis Mytilineos, Thomas Moehler, et al.. (2002). Polymorphisms of the tumor necrosis factor-α gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood. 100(6). 2263–2265. 68 indexed citations
18.
Glasmacher, Axel, Hendrik Pels, Christoph Helmstaedter, et al.. (2001). Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: Superior results in patients younger than 60 years. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
19.
Neben, Kai, Michael Werner, L. Bernd, et al.. (2001). A man with hereditary exostoses and high-grade non-Hodgkin's lymphoma of the bone. Annals of Hematology. 80(11). 682–684. 5 indexed citations
20.
Moehler, Thomas, H. Hawighorst, Kai Neben, et al.. (2000). Funktioelle Magnetresonanztomographie in Diagnostik und Therapiemonitoring beim Multiplen Myelom. Der Radiologe. 40(8). 723–730. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shmuel Yaccoby Breakdown of academic impact, for papers by Diane C. Arthur Breakdown of academic impact, for papers by Luen Bik To Breakdown of academic impact, for papers by A Hagemeijer Breakdown of academic impact, for papers by Sergej Konoplev Breakdown of academic impact, for papers by Nicole Dastugue Breakdown of academic impact, for papers by Bruno Paiva Breakdown of academic impact, for papers by Stefan Hohaus Breakdown of academic impact, for papers by Juan Luis Garcı́a Breakdown of academic impact, for papers by Scott Ely
Rankless by CCL
2026